Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Adicet Bio, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 64
- 0 vs. Q3 2024
- Shares held
- 57.6M
- +490.3K (+0.9%) vs. Q3 2024
- Total value
- $55.4M
- −$26.8M (−32.6%) vs. Q3 2024
- New holders
- 7
- 16 more added
- Sold out
- 7
- 23 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACET on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $52.8M |
| Q1 2026 | 49 | $43.7M |
| Q4 2025 | 49 | $56.6M |
| Q3 2025 | 54 | $41.6M |
| Q2 2025 | 49 | $31.5M |
| Q1 2025 | 56 | $42.0M |
| Q4 2024 | 64 | $55.4M |
| Q3 2024 | 64 | $82.3M |
| Q2 2024 | 86 | $77.4M |
| Q1 2024 | 98 | $176.6M |
| Q4 2023 | 77 | $63.0M |
| Q3 2023 | 84 | $48.9M |
| Q2 2023 | 95 | $90.4M |
| Q1 2023 | 107 | $231.3M |
| Q4 2022 | 100 | $375.7M |
| Q3 2022 | 102 | $590.7M |
| Q2 2022 | 101 | $555.9M |
| Q1 2022 | 88 | $660.4M |
| Q4 2021 | 81 | $531.2M |
| Q3 2021 | 58 | $156.1M |
| Q2 2021 | 66 | $218.1M |
| Q1 2021 | 54 | $266.3M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Adicet Bio, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lazard Asset Management LLC | 414 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 357 | $0 | 0.00% | +357 | New |
| Barclays PLC | 14 | $13 | 0.00% | −37−72.5% | Reduced |
| Thompson Investment Management, Inc. | 80 | $77 | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 95 | $91 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 168 | $162 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 171 | $165 | 0.00% | +171 | New |
| Citigroup Inc | 242 | $232 | 0.00% | −142−37.0% | Reduced |
| BNP Paribas Arbitrage, SA | 894 | $860 | 0.00% | +894 | New |
| Hollencrest Capital Management | 900 | $866 | 0.00% | +600+200.0% | Added |
| Morgan Stanley | 7,925 | $7.62K | 0.00% | −260,984−97.1% | Reduced |
| Group One Trading, L.P. | 11,200 | $10.8K | 0.00% | +9,000+409.1% | Added |
| Jane Street Group, LLC | 12,312 | $11.8K | 0.00% | −62,455−83.5% | Reduced |
| Cubist Systematic Strategies, LLC | 12,516 | $12.0K | 0.00% | −77,356−86.1% | Reduced |
| Simplex Trading, LLC | 14,475 | $13.0K | 0.00% | +8,052+125.4% | Added |
| Gsa Capital Partners LLP | 16,762 | $16.0K | 0.00% | −22,446−57.2% | Reduced |
| Caxton Corp | 17,488 | $16.8K | 0.10% | 00.0% | Unchanged |
| Citadel Advisors LLC | 20,246 | $19.5K | 0.00% | −22,864−53.0% | Reduced |
| Prelude Capital Management, LLC | 28,909 | $27.8K | 0.00% | −11,071−27.7% | Reduced |
| Charles Schwab Investment Management Inc | 30,000 | $28.9K | 0.00% | −40−0.1% | Reduced |
| Virtu Financial LLC | 30,611 | $29.0K | 0.00% | +30,611 | New |
| Bank of America Corp | 37,363 | $35.9K | 0.00% | −32,869−46.8% | Reduced |
| Point72 Asia (Singapore) Pte. Ltd. | 39,997 | $38.5K | 0.01% | −1,118−2.7% | Reduced |
| Marshall Wace, LLP | 40,306 | $38.7K | 0.00% | −104,894−72.2% | Reduced |
| Castleview Partners, LLC | 47,903 | $46.6K | 0.03% | −4,465−8.5% | Reduced |
| Vontobel Holding Ltd. | 50,000 | $48.1K | 0.00% | +10,000+25.0% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 51,175 | $49.2K | 0.00% | −129,618−71.7% | Reduced |
| XTX Topco Ltd | 68,197 | $65.6K | 0.01% | −223,983−76.7% | Reduced |
| Wealthedge Investment Advisors, LLC | 73,764 | $71.0K | 0.03% | +73,764 | New |
| Diametric Capital, LP | 85,517 | $82.3K | 0.06% | −24,266−22.1% | Reduced |
| Exchange Traded Concepts, LLC | 111,642 | $107.4K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 136,107 | $130.9K | 0.00% | +5,157+3.9% | Added |
| Northern Trust Corp | 140,369 | $135.0K | 0.00% | +28,153+25.1% | Added |
| Dimensional Fund Advisors LP | 147,814 | $142.1K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 150,485 | $144.8K | 0.00% | +70,132+87.3% | Added |
| Squarepoint Ops LLC | 184,356 | $177.3K | 0.00% | +184,356 | New |
| UBS Group AG | 203,229 | $195.5K | 0.00% | +161,625+388.5% | Added |
| State Street Corp | 246,921 | $237.5K | 0.00% | +17,200+7.5% | Added |
| FMR LLC | 305,907 | $294.3K | 0.00% | +29,738+10.8% | Added |
| Johnson & Johnson | 364,472 | $350.6K | 0.09% | 00.0% | Unchanged |
| Norges Bank | 429,550 | $413.2K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 477,675 | $459.5K | 0.00% | +113,333+31.1% | Added |
| DAFNA Capital Management LLC | 600,000 | $577.2K | 0.15% | 00.0% | Unchanged |
| RBF Capital, LLC | 601,135 | $578.3K | 0.03% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 655,665 | $630.8K | 0.00% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 700,000 | $673.4K | 0.54% | +90,554+14.9% | Added |
| Two Sigma Investments, LP | 703,361 | $676.6K | 0.00% | −580.0% | Reduced |
| Geode Capital Management, LLC | 767,541 | $738.6K | 0.00% | −1,025−0.1% | Reduced |
| Two Sigma Advisers, LP | 794,039 | $763.9K | 0.00% | +87,400+12.4% | Added |
| BlackRock, Inc. | 811,776 | $780.9K | 0.00% | +59,767+7.9% | Added |
| D. E. Shaw & Co., Inc. | 847,064 | $814.9K | 0.00% | −70,006−7.6% | Reduced |
| Renaissance Technologies LLC | 916,500 | $881.7K | 0.00% | −315,100−25.6% | Reduced |
| Regeneron Pharmaceuticals, Inc. | 968,183 | $931.4K | 0.09% | +968,183 | New |
| Bridgeway Capital Management, LLC | 1,026,600 | $987.6K | 0.02% | +175,000+20.5% | Added |
| Blackstone Group Inc. | 1,236,453 | $1.19M | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 1,814,314 | $1.75M | 0.00% | −144,413−7.4% | Reduced |
| Acadian Asset Management LLC | 2,003,047 | $1.93M | 0.01% | +123,114+6.5% | Added |
| Aquilo Capital Management, LLC | 2,531,194 | $2.44M | 4.17% | 00.0% | Unchanged |
| Carlyle Group Inc. | 2,948,718 | $2.84M | 0.07% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,205,882 | $3.08M | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 3,752,865 | $3.61M | 0.00% | −7,132−0.2% | Reduced |
| Ra Capital Management, L.P. | 7,541,000 | $7.25M | 0.10% | 00.0% | Unchanged |
| Tang Capital Management LLC | 8,145,988 | $7.84M | 0.52% | −70,972−0.9% | Reduced |
| OrbiMed Advisors LLC | 11,447,140 | $11.0M | 0.23% | 00.0% | Unchanged |
| Bank of Montreal | 0 | $0 | 0.00% | −78,704−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −23,296−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −21,496−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −18,074−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −13,700−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −12,621−100.0% | Sold out |
| Northwest Financial Advisors | 0 | $0 | 0.00% | −1,685−100.0% | Sold out |